Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01170611 · ClinicalTrials.gov registry record · Phase 4
Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease
A Phase 4 study, sponsored by LivaNova.
- Completed
- Registry status
- Phase 4
- Development phase
- 400
- Enrollment target
NCT01170611: Completed Phase 4 study, sponsored by LivaNova.
NCT01170611 is a Phase 4 study that has completed, run by LivaNova. The registered enrollment target is 400 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01170611, a Phase 4 study, has completed, sponsored by LivaNova.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 400 participants
- Enrollment target
Study Summary
This clinical investigation is a prospective, single-blinded, randomized trial. The primary objective concerns the safety and effectiveness of the AAIsafeR mode with the preventive algorithms.
Interventions
- DEVICE PACEMAKER SYMPHONY 2550
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-01 |
| Phase | Phase 4 |
What the finished NCT01170611 record still lists
NCT01170611 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 1 intervention - of which PACEMAKER SYMPHONY 2550 is the first listed.
NCT01170611 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01170611 about?
NCT01170611 is a clinical study titled "Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease". This clinical investigation is a prospective, single-blinded, randomized trial. The primary objective concerns the safety and effectiveness of the AAIsafeR mode with the preventive algorithms.
What is the current status of trial NCT01170611?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 400 participants. The study started on 2004-07. Estimated completion is 2007-01.
What interventions are being tested in trial NCT01170611?
The interventions under investigation include: PACEMAKER SYMPHONY 2550 (DEVICE).
Who is sponsoring clinical trial NCT01170611?
This trial is sponsored by LivaNova, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01170611's enrollment target sits among peer trials
400 211th of 2000 higher than 1,784 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia